Delivery Order SPE2DB20D9127-SPE2DB25FPRK3
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. The award was issued without a set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order covers the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions, with an ultimate completion date of September 22, 2025. This award was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on July 18, 2025. The delivery order, which must be completed by August 8, 2025, is for Stelara 90 mg/mL syringes and was issued without a set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $97.5K firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/mL syringes. The contract carries an ultimate completion date of October 2, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/mL syringes. This firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency (DLA) on August 8, 2025. This firm fixed-price delivery order is for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of August 29, 2025. The contract utilizes no set-aside designation, demonstrating the company's competitive positioning in federal procurement markets. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRK3Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for Stelara 90 mg/ml syringes. The contract ceiling value is $32,499.90, with an ultimate completion date of October 1, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive positioning in federal pharmaceutical procurement. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters and primary operations. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.99 million blanket agreement through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical supplies supporting military health facilities worldwide. Stelara, a biologic injection used for treating autoimmune conditions, aligns with the company's established portfolio of specialty pharmaceutical products delivered to the Department of Defense healthcare system. Through this vehicle, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of branded and generic prescription drugs, biologics, and medical consumables to military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 9/10/25 |